Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISAC Desrumaux, A Athias, G Bessède, et al.
Journal of Lipid Research|February 20, 1998
Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitusS Bernard, P Moulin, L Lagrost, et al.
Diabetes & Metabolism|March 4, 2016
Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration, but not visceral fat, in patients with type 2 diabetesB Bouillet, T Gautier, L S Aho, et al.
The Journal of Biological Chemistry|August 9, 1996
Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patientsL Lagrost, A Athias, B Herbeth, et al.
Diabetes|January 1, 1997
Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDMB L Vergès, L Lagrost, G Vaillant, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Increased cholesteryl ester transfer activity in plasma from analbuminemic patientsS Braschi, L Lagrost, E Florentin, et al.
Journal of Lipid Research|October 1, 1996
Effect of lipid transfer activity and lipolysis on low density lipoprotein (LDL) oxidizability: evidence for lipolysis-generated non-esterified fatty acids as inhibitors of LDL oxidationL Viens, A Athias, G Lizard, et al.
Diabetes & Metabolism|February 14, 2007
Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patientsF Galland, L Duvillard, J M Petit, et al.
The Journal of Biological Chemistry|June 2, 1995
Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-IIL Lagrost, C Dengremont, A Athias, et al.
Metabolism: Clinical and Experimental|August 26, 1998
Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activityD Sich, Y Saïdi, P Giral, et al.
Pageof 7